NewsBenzingaOppenheimer Upgrades Incyte to Outperform, Raises Price Target to $144 Oppenheimer Upgrades Incyte to Outperform, Raises Price Target to $144 Benzinga 2026.10.30 09:27 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Overweight on Stagwell, Raises Price Target to $12 TD Cowen Maintains Buy on Alphatec Holdings, Lowers Price Target to $10 Wells Fargo Maintains Underweight on Vulcan Materials, Raises Price Target to $253 TD Cowen Maintains Buy on Alnylam Pharmaceuticals, Lowers Price Target to $354 Wells Fargo Maintains Overweight on CRH, Lowers Price Target to $100 TD Cowen Maintains Buy on Amazon.com, Lowers Price Target to $340
